Howard J. Weisman - 08 Mar 2023 Form 4 Insider Report for PaxMedica, Inc.

Signature
/s/ Stephen D. Sheldon, Jr. Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
08 Mar 2023
Net transactions value
-$52,332
Form type
4
Filing time
09 Mar 2023, 20:47:49 UTC
Previous filing
07 Mar 2023
Next filing
14 Apr 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PXMD Common Stock Sale $47,300 -32,397 -5.6% $1.46 545,128 08 Mar 2023 Direct F1, F2
transaction PXMD Common Stock Sale $5,033 -3,495 -0.64% $1.44 541,633 09 Mar 2023 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to the Reporting Person's pre-existing Rule 10b5-1 trading plan. Shares were sold by the Reporting Person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of restricted stock units granted to the Reporting Person.
F2 This sale price represents the weighted average sale price of the shares sold ranging from $1.53 to $1.42 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3 This sale price represents the weighted average sale price of the shares sold ranging from $1.54 to $1.42 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.